Quick Answer
Karyopharm Therapeutics Inc. reported Common Stock Shares Outstanding of 18.31 million shares for the year ending 2025.
- Karyopharm Therapeutics Inc. showed an increase of +117.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Karyopharm Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: 29.62 million shares | Q2 2014: 29.72 million shares | Q3 2014: 32.61 million shares | Q1 2015: 35.69 million shares | Q2 2015: 35.70 million shares | Q3 2015: 35.71 million shares | Q1 2016: 35.92 million shares | Q2 2016: 35.99 million shares | Q3 2016: 39.72 million shares | Q1 2017: 41.90 million shares | Q2 2017: 47.12 million shares | Q3 2017: 47.15 million shares | Q1 2018: 49.67 million shares | Q2 2018: 60.50 million shares | Q3 2018: 60.66 million shares | Q1 2019: 60.86 million shares | Q2 2019: 60.97 million shares | Q3 2019: 62.71 million shares | Q1 2020: 73.10 million shares | Q2 2020: 73.37 million shares | Q3 2020: 73.53 million shares | Q1 2021: 75.06 million shares | Q2 2021: 75.33 million shares | Q3 2021: 75.50 million shares | Q1 2022: 79.42 million shares | Q2 2022: 79.80 million shares | Q3 2022: 81.03 million shares | Q1 2023: 113.97 million shares | Q2 2023: 114.34 million shares | Q3 2023: 114.52 million shares | Q1 2024: 116.46 million shares | Q2 2024: 124.64 million shares | Q3 2024: 125.30 million shares | Q1 2025: 8.57 million shares | Q2 2025: 8.65 million shares | Q3 2025: 8.70 million shares.
- Over the full 14 years of available data (2012 to 2025), Karyopharm Therapeutics Inc.'s Common Stock Shares Outstanding has grown by 762.3%.
- Historical annual values: Fiscal year 2025: 18.31 million shares | Fiscal year 2024: 8.41 million shares | Fiscal year 2023: 114.92 million shares | Fiscal year 2022: 113.21 million shares | Fiscal year 2021: 75.75 million shares | Fiscal year 2020: 73.92 million shares | Fiscal year 2019: 65.37 million shares | Fiscal year 2018: 60.83 million shares | Fiscal year 2017: 49.53 million shares | Fiscal year 2016: 41.89 million shares | Fiscal year 2015: 35.86 million shares | Fiscal year 2014: 32.70 million shares | Fiscal year 2013: 29.59 million shares | Fiscal year 2012: 2.12 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: